Strides Pharma Science Ltd
NSE:STAR

Watchlist Manager
Strides Pharma Science Ltd Logo
Strides Pharma Science Ltd
NSE:STAR
Watchlist
Price: 1 415.3 INR 1.9%
Market Cap: 130.1B INR
Have any thoughts about
Strides Pharma Science Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

15.4
Current
11.6
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
15.4
=
Enterprise Value
133.1B INR
/
EBITDA
8.7B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
13.3
2-Years Forward
EV/EBITDA
11.4
3-Years Forward
EV/EBITDA
10

See Also

Discover More